SQA

DECEMBER 16, 2022

SQA Regulatory Surveillance Summary for September and October 2022. ANVISA’s Questions & Answers (Q&A) on Medical Cannabis for Clinical Investigations, 14 September 2022. ANVISA published answers to questions received during an online seminar on clinical research of medicinal cannabis held in May 2022. 30 of 2022.

FDA 40

FDA Compliance COVID-19 Licensing 40

SQA

FEBRUARY 26, 2024

European Commission (EC) New Measures to Fight Organized Crime and Drug Trafficking, 18 October 2023 In 2021 alone, 303 tons of cocaine were seized in the EU. To step up the fight against criminal networks, the Commission has implemented new measures to fight organized crime and the drug trade.

FDA 52

FDA Compliance COVID-19 Public Health 52

SQA

MAY 24, 2023

Following the draft consultation in November 2022, the NMPA announced the issuance of the Regulations on the Supervision and Management of Enterprises Implementing the Main Responsibility for the Quality and Safety of Medical Devices , which will come into force on 01 March 2023.

FDA 40

FDA Licensing Governance Compliance 40